[
    {
        "title": "Schizophrenia Player BioXcel's Drug Faces Funding Headwinds, Analyst Downgrades Stock - BioXcel Therapeut - Benzinga",
        "description": "Schizophrenia Player BioXcel's Drug Faces Funding Headwinds, Analyst Downgrades Stock - BioXcel Therapeut  Benzinga",
        "published date": "Thu, 05 Oct 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiwFodHRwczovL3d3dy5iZW56aW5nYS5jb20vZ2VuZXJhbC9iaW90ZWNoLzIzLzEwLzM1MTEzNjgyL3NjaGl6b3BocmVuaWEtcGxheWVyLWJpb3hjZWxzLWRydWctZmFjZXMtZnVuZGluZy1oZWFkd2luZHMtYW5hbHlzdC1kb3duZ3JhZGVzLXN0b2Nr0gEtaHR0cHM6Ly93d3cuYmVuemluZ2EuY29tL2FtcC9jb250ZW50LzM1MTEzNjgy?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    }
]